U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Resources for You | Drugs
  4. Information for Industry | Drugs
  1. Resources for You | Drugs

Information for Industry | Drugs

Search databases for regulatory information on all aspects of the drug development and approval process, submit drug applications, pay user fees, get small business assistance.


Three arrows

Guidances related to drugs

Documents representing FDA's current thinking on a particular subject

Search FDA Guidances

Spilled bottle of pills

Drug Approvals and Databases

Approvals and medications—Drugs@FDA, FDALabel, Orange Book, and more

Female scientist holding a red capsule pill

Development and Approval Process

Drug applications, submissions, manufacturing, and small business help

CDER subtopic woman wearing headset

CDER Small Business and Industry Assistance

Human drug development and regulation, conferences, webinars, training courses, and more

Microphone in conference hall

Advisory Committees

Independent opinions and recommendations from outside experts on applications to market new drugs and on FDA policies

Use filter and search box to find resources

Webpage Topic
About FDA About FDA and CDER
CDER Ombudsman About FDA and CDER
Doing Business With FDA About FDA and CDER
CDER Exclusivity Board About FDA and CDER
Jobs at FDA About FDA and CDER
Phonetic and Orthographic Computer Analysis (POCA) Program Application Forms, Submission Requirements & User Fees
Investigational New Drug (IND) Application Application Forms, Submission Requirements & User Fees
New Drug Application (NDA) Application Forms, Submission Requirements & User Fees
Abbreviated New Drug Application (ANDA) Application Forms, Submission Requirements & User Fees
Patent Certifications and Suitability Petitions Application Forms, Submission Requirements & User Fees
Therapeutic Biologics Applications (BLA) Application Forms, Submission Requirements & User Fees
Drug Applications for Over-the-Counter (OTC) Drugs Application Forms, Submission Requirements & User Fees
User Fees (BsUFA, GDUFA, OMUFA, PDUFA) Application Forms, Submission Requirements & User Fees
Electronic Regulatory Submission and Review Application Forms, Submission Requirements & User Fees
CDER Data Standards Program Application Forms, Submission Requirements & User Fees
Drugs@FDA Approvals and Databases
FDALabel Approvals and Databases
Orange Book Approvals and Databases
Drug Approvals and Databases Approvals and Databases
Acronyms and Abbreviations Search Approvals and Databases
CDER Direct: Electronic Submissions Portal Approvals and Databases
CDER Small Business and Industry Assistance (SBIA) CDER Small Business and Industry Assistance
CDER SBIA Learn: Webinars, Conferences & Trainings CDER Small Business and Industry Assistance
Development & Approval Process  Development and Approval Process 
Advisory Committees (human drugs) Development and Approval Process 
Generic Drugs: Information for Industry Development and Approval Process 
Patent Certifications and Suitability Petitions Development and Approval Process 
Biosimilars Development and Approval Process 
Biomarker Qualification Program Development and Approval Process 
Developing Products for Rare Diseases and Conditions Development and Approval Process 
Expanded Access: Information for Industry Development and Approval Process 
USP Monograph Modernization Program Development and Approval Process 
CDER Data Standards Program Development and Approval Process 
Phonetic and Orthographic Computer Analysis (POCA) Program Development and Approval Process 
CDER Small Business & Industry Assistance (SBIA) Development and Approval Process 
Guidance, Compliance, and Regulatory Information Guidance, Compliance & Regulatory Information
Guidances (Drugs) Guidance, Compliance & Regulatory Information
Warning Letters and Notice of Violation Letters to Pharmaceutical Companies Guidance, Compliance & Regulatory Information
Prescription Drug Labeling Resources Guidance, Compliance & Regulatory Information
Drug Safety and Availability Information, Safety, and Availability
Postmarket Drug Safety Information for Patients and Providers Information, Safety, and Availability
Phonetic and Orthographic Computer Analysis (POCA) Program Information, Safety, and Availability
Pharmaceutical Quality Resources Quality and Manufacturing
Drug Supply Chain Security Act  Quality and Manufacturing
Report a Product Quality Issue Quality and Manufacturing
Division of Drug Information (DDI) Webinars Training and Education
FDA Drug Info Rounds A series of training videos for practicing clinical and community pharmacists Training and Education
Truthful Prescription Drug Advertising and Promotion (Bad Ad Program) Training and Education
CDERLearn Training and Education Training and Education


Back to Top